These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 19056837

  • 1. Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements.
    Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE.
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):552-8. PubMed ID: 19056837
    [Abstract] [Full Text] [Related]

  • 2. Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas.
    Hu LS, Baxter LC, Pinnaduwage DS, Paine TL, Karis JP, Feuerstein BG, Schmainda KM, Dueck AC, Debbins J, Smith KA, Nakaji P, Eschbacher JM, Coons SW, Heiserman JE.
    AJNR Am J Neuroradiol; 2010 Jan; 31(1):40-8. PubMed ID: 19749223
    [Abstract] [Full Text] [Related]

  • 3. Preoperative Grading of Glioma Using Dynamic Susceptibility Contrast MRI: Relative Cerebral Blood Volume Analysis of Intra-tumoural and Peri-tumoural Tissue.
    Soliman RK, Gamal SA, Essa AA, Othman MH.
    Clin Neurol Neurosurg; 2018 Apr; 167():86-92. PubMed ID: 29471287
    [Abstract] [Full Text] [Related]

  • 4. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS, Kelm Z, Korfiatis P, Dueck AC, Elrod C, Ellingson BM, Kaufmann TJ, Eschbacher JM, Karis JP, Smith K, Nakaji P, Brinkman D, Pafundi D, Baxter LC, Erickson BJ.
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
    [Abstract] [Full Text] [Related]

  • 5. Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma.
    Hu LS, Eschbacher JM, Dueck AC, Heiserman JE, Liu S, Karis JP, Smith KA, Shapiro WR, Pinnaduwage DS, Coons SW, Nakaji P, Debbins J, Feuerstein BG, Baxter LC.
    AJNR Am J Neuroradiol; 2012 Jan; 33(1):69-76. PubMed ID: 22095961
    [Abstract] [Full Text] [Related]

  • 6. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
    Xu Q, Liu Q, Ge H, Ge X, Wu J, Qu J, Xu K.
    Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Posttreatment recurrence of malignant brain neoplasm: accuracy of relative cerebral blood volume fraction in discriminating low from high malignant histologic volume fraction.
    Gasparetto EL, Pawlak MA, Patel SH, Huse J, Woo JH, Krejza J, Rosenfeld MR, O'Rourke DM, Lustig R, Melhem ER, Wolf RL.
    Radiology; 2009 Mar; 250(3):887-96. PubMed ID: 19244052
    [Abstract] [Full Text] [Related]

  • 9. Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma.
    Anil A, Stokes AM, Chao R, Hu LS, Alhilali L, Karis JP, Bell LC, Quarles CC.
    Front Oncol; 2023 Mar; 13():1046629. PubMed ID: 36733305
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting.
    Bruening R, Kwong KK, Vevea MJ, Hochberg FH, Cher L, Harsh GR, Niemi PT, Weisskoff RM, Rosen BR.
    AJNR Am J Neuroradiol; 1996 May; 17(5):831-40. PubMed ID: 8733954
    [Abstract] [Full Text] [Related]

  • 12. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N.
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
    Gahramanov S, Muldoon LL, Li X, Neuwelt EA.
    Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
    [Abstract] [Full Text] [Related]

  • 15. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES, Schmainda KM.
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [Abstract] [Full Text] [Related]

  • 16. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence.
    Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, Wannenmacher M.
    Int J Radiat Oncol Biol Phys; 2000 Aug 01; 48(1):53-8. PubMed ID: 10924971
    [Abstract] [Full Text] [Related]

  • 17. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D.
    AJNR Am J Neuroradiol; 2003 Aug 01; 24(10):1989-98. PubMed ID: 14625221
    [Abstract] [Full Text] [Related]

  • 18. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H, Aydin O, Ozturk-Isik E, Gumus C, Inecikli F, Bekar A, Kocaeli H, Hakyemez B.
    Eur J Radiol; 2014 Oct 01; 83(10):1914-9. PubMed ID: 25087109
    [Abstract] [Full Text] [Related]

  • 19. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
    Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S.
    Acad Radiol; 2013 Dec 01; 20(12):1557-65. PubMed ID: 24200483
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study.
    Nguyen TB, Zakhari N, Velasco Sandoval S, Guarnizo-Capera A, Alexios Gulak M, Woulfe J, Jansen G, Thornhill R, Majtenyi N, Cron GO.
    AJNR Am J Neuroradiol; 2023 Feb 01; 44(2):134-142. PubMed ID: 36702501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.